3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
25
Ovarian Neoplasms
19
Neoplasms
12
Fallopian Tube Neoplasms
12
Carcinoma, Hepatocellular
11
Endometrial Neoplasms
7
Neoplasm Metastasis
6
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Glioblastoma
4
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Rectal Neoplasms
3
Lung Neoplasms
3
Liver Neoplasms
3
Digestive System Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Mouth Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Intestinal Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Brenner Tumor
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Astrocytoma
2
Interventions
Vincristine
2
Rituximab
2
Prednisone
2
Etoposide
2
Doxorubicin
2
Cyclophosphamide
2
liposomal doxorubicin
1
etoposide phosphate
1
Zidovudine
1
Valganciclovir
1
Sirolimus
1
Nivolumab
1
Interferon-alpha
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Bortezomib
1
Biological Assay
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
Bevacizumab
×
30 days
×
Clear all
No trials found.